Snakebite Envenoming Treatment Model
Snakebite Envenoming Treatment Model
038 - 059
INTERNATIONAL
INTERNATIONALJOURNAL
JOURNALOF
OFDEVELOPMENT
DEVELOPMENTMATHEMATICS
MATHEMATICS
Modeling the Impacts of Diagnosis and Treatment of Snakebite Envenoming Victims with
Anti-Snake Venom in a Community
Joseph S. Ayubaa*, Musa Abdullahib and Patience B. Iliyaa
aDepartment of Mathematics and Statistics, Federal University of Kashere, Gombe State, Nigeria.
bDepartment of Mathematics, Modibbo Adama University, Yola, Adamawa State, Nigeria.
ABSTRACT
ARTICLE INFO Snakebite envenoming (SBE) is one of the major causes of deaths and disabilities in tropical
and subtropical countries especially in the continents of Asia and Africa. Report revealed that
Article history: on average, 5-8 and about 3,000 cases of SBE are recorded daily and yearly respectively in
Received 17 March 2024 northeast Nigeria which population are largely agriculturists. Thus, snakebite (SB) led to
Received in revised form 05 June 2024 economy setback and slows down productivity among the workforce as a result of disabilities
Accepted 29 July 2024 induced by SBE. Consequently, the revenue generation even including income facing
declined. This paper proposes population-based mathematical model for studying the dynamic
impacts of diagnosis and treatment of snakebite envenoming victims with anti-snake venom
Keywords:
in a community. The model is rigorously analyzed using relevant techniques and theorems in
Anti-snake venom, Mathematical
model, Nneglected tropical diseases dynamical systems. The model was validated using monthly reported data on snakebite
Snakebite envenoming, Stability envenoming from 2020–2022, collected from snakebite treatment and research hospital
analysis (STRH) Kaltungo in northeast Nigeria. The qualitative study revealed that the model has
snakebite-envenoming-free and snakebite-envenoming-endemic equilibrium points. It is
shown via the Lyapunov function in conjunction with the Lassale invariance principle that
MSC 2020 Subject classification: these two equilibrium points are globally asymptotically stable. Furthermore, numerical
92-10 92D30 34D20 34D23 65L07 simulations of the model were carried out to investigate the impact of the diagnosis of
snakebite envenoming victims and the treatment of the same on the burden of snakebite
envenoming. The results of the simulations revealed that appropriate diagnosis and treatment
of snakebite envenoming victims with anti-snake venom could significantly reduce the
number of snakebite-induced deaths and disabilities. This work can serve as a framework for
making policy and decision in addressing the issues of SBE in the public healthcares in the
study region and beyond.
1. Introduction
Snakebite (SB) is an injury caused by a bite from a snake, resulting in puncture wounds inflicted by the fangs,
while snakebite envenoming (SBE) is a potentially life-threatening disease which occurs as a result of an injection of
a complex mixture of different toxins following the bite of a venomous snake (Warrell, 2010 and Williams, et al,.
2019). The severity of snakebite depends on some factors, such as the kind of snake, the part of the body bitten, the
quantity of venom injected, and the general health of the person bitten (Abdullahi, Habib & Hussaini, 2021). Generally,
there are more than 3000 species of snakes in the world, and they live in terrestrial and aquatic ecosystems. They are
predatory carnivores with a wide range of prey species. Approximately 15% of the 3000 species of snakes worldwide
are considered dangerous to humans and responsible for significant morbidity and mortality, (WHO, 2017; Gold, Dart
& Barish, 2002). Snake venom is the most complex of all natural venoms and poisons and it varies in composition
from species to species, (Menez, 2003). There is a considerable variation also in the venom constituents within a single
species within a geographical distribution at different season (Warrel, 1996). The four key toxins of snake venom
includes serine protein (SVSP), three finger toxins (3FTx), phospholipase A 2 (PLA2) and snake venom
metalloproteinease (SVMP), (Casewell & Clevers, 2020).
SBE is a significant public health concern in many parts of the world, particularly in rural areas of tropical and
subtropical regions. It is estimated that 1.7 billion lives globally are threatened annually by neglected tropical diseases,
of which SBE is among them. An estimated 5.4 million cases of SB occur every year, and it is responsible for causing
around 2.7 million cases of envenoming, with about 138,000 cases of deaths and more than 400,000 people suffering
from disabilities around the world, (Warrell, 2010; Williams, et al,. 2019 and WHO, 2019). SBE is most prevalent in
Africa, Asia, and Latin America. According to research, individuals living in rural areas of these regions are at a higher
risk of SBE due to their occupational exposure to snakes. SBE causes morbidity and mortality among farmers,
pastoralists, hunters, and children, (WHO, 2019; Longbottom, et al., and Gampin, Nassouri, Chippaux & Semde, 2016).
Those who suffered the most from SB are the young agriculturists, the most economically productive group, followed
by children, (Warrell, 2010 & WHO, 2019).
SBE can lead to a wide range of clinical manifestations, including local effects (such as pain, swelling, and tissue
damage), systemic effects (such as bleeding disorders, cardiovascular collapse, and renal failure), and neurotoxic
effects (such as paralysis and respiratory failure). Limited access to healthcare facilities, especially in rural areas, is a
major challenge in the management of SBE. This often results in delayed treatment and increased morbidity and
mortality, (Gutierrez et al., 2017). SBE can be treated when adequately diagnosed. Usually, the clinical outcomes of
the diagnosis of SBE cases for management can be classified as mild, moderate, or severe. The toxicity effects induced
by SBE are currently treated with intravenous administration of anti-snake venom (ASV) in combination with analgesic
fluid therapy, hemodialysis, and/or antibiotics, (Harrison & Williams, 2019; Gutierrez, et al., 2007 and Gutierrez et
al., 2017). The availability and accessibility of effective ASV are crucial for treating SBE. However, some studies have
shown significant challenges related to the production, distribution, and affordability of ASV in many affected regions
(Habib & Brown 2018 and Gutiérrez, 2018).
Despite the dangers posed by snakes, they benefit humans by killing unwanted insects and rodents in food stores
and farms, (Katie & Kennymac, 2013 and Abdullahi, Musa, He & Bello 2021). Snake-skins are used to make shoes,
handbags, and other articles. And snake park serve as tourism attractions. The venom is used for producing life-saving
ASV, biomedical research and other medicinal products, and to control infections such as protozoan infections, cancers,
and so on, (Abubakar et al., 2010; Agom, Moses & Priti,.2022; Alams & Gomes, 2003; Zainal Abidin, Lee, Lekhsan
& Rakesh, 2019 and Hussaini, Okuneye & Gumel, 2017).
It is noteworthy to mention that several mathematical models have been developed to understand the
transmission dynamics and control of some neglected tropical diseases, such as Leishmaniasis, Rabies, Chikungunya,
Dengue, Chagas disease, Onchocerciasis, Lymphatic Filariasis, and Schistosomiasis See, for instance, Adamu &
Hussaini, 2019; Shigui, 2017; Zhang, Jin, Sun, Zhou & Ruan, 2011; Yakob & Clements 2013; Sabiu & Hussaini,
2017; Bhunu & Mushayabasa, 2012; Dumont & Chiroleu 2010; Omondi, Nyabadza, Bonyah, & Badu, 2017; Sabiu,
Hussaini, Zhao & Daihai, 2020 and Woolhouse, 1992) and references therein. Unlike some of those mentioned
neglected tropical diseases, it has been recognized to the best of the authors’ knowledge that not many mathematical
models have been constructed to analyze the dynamics and control of SBE. However, some few researches include
prediction of snake distributions in relation to its transmission using ecological niche modeling, estimation of incidence
of snakebite by application of the law of mass action, Goldstein, Erinjery, Martin, Kasturiratne, Ediriweera & de Silva
(2021) predicting snakebite risk using species distribution model Casewell & Clevers (2020), mathematical model
based on social demography, economic and health infrastructure to examine the impact of behavior on the overall
mortality outcomes of snakebite victims Goldstein et al., (2021) and evaluation of intervention strategies with effective
cost in management of snakebite using mechanistic model (Yañez-Arenas, Peterson, Mokondoko, Rojas-Soto &
Martínez-Meyer, 2014). Some of other few ones can be found in the following studies (Abdullahi, Habib & Hussaini,
2021; Bravo-Vega, Santos-Vega, Juan & Cordovez, 2021; Martin, Erinjery, Ediriweera, de Silva, Lalloo, Iwamura &
Murray, 2022; Kumar, Vedat Suat Erturk, Govindaraj, & Baleanu, 2023 and Abdullahi, Habib. & Hussaini, 2024) and
references therein.
In management of snakebite, effective treatment is associated to proper diagnosis (mild, moderate and severe)
of victim of snakebite envenoming which were not captured in previous SBE models. Therefore, this study aims to
develop a population-based mathematical model to investigate the impacts of the diagnosis of SBE victims and their
treatment with ASV on the dynamics of SBE. A notable feature of the model is the incorporation of the rate of diagnosis
of SBE victims with three different conditions, mild, moderate, and severe. The model also includes the death rate of
snakes due to human activities. The paper is organized as follows: The model is formulated in Section 2, and the
analysis of the mathematical properties of the model and its validation via model fitting are presented in Section 3.
The numerical simulations are explored in Section 4, and the conclusion is presented in Section 5.
2. Methods
population of SBE victims diagnosed with mild conditions ( I ( t ) ) , population of SBE victims diagnosed with
ml
moderate conditions ( I ( t ) ) , population of SBE victims diagnosed with severe conditions ( I ( t ) ) , population of
mo s
SBE victims receiving treatment with ASV ( T ( t ) ) , population of persons suffering from early adverse reactions
during treatment with ASV ( E ( t ) ) , population of persons who recovered with disability ( R ( t ) ) and population
ar d
of persons who recovered without disability ( R ( t ) ) . Thus, the total human population is given by
w
N h ( t ) = S ( t ) + I ( t ) + I ml ( t ) + I mo ( t ) + I s ( t ) + T ( t ) + Ear ( t ) + Rd (t ) + Rw (t ) . (1)
The total population of venomous snakes is represented by (V ( t ) ) . In this work, susceptible persons refer to
s
those at risk of being bitten by a venomous snake. The population of susceptible persons is generated by a constant
recruitment rate given by h , recovered persons with disabilities and without disabilities who become susceptible
again at the rates1 and 2 respectively. It diminishes by susceptible persons who become victims of SBE at a rate
and natural death rate h . Thus, the equation governing the dynamics of the susceptible population is given by
dS
= h + 1Rd + 2 Rw − ( + h ) S , (2)
dt
where
Vs
= and is the effective contact rate between venomous snakes and humans.
Nh
The population of undiagnosed SBE victims is generated by susceptible persons who are bitten by snakes and
become victims of SBE as given by S . The population decreased due to the diagnosis of SBE victims with mild,
moderate and severe conditions at the rates, 1 , 2 and 3 respectively. It also diminishes due to SBE-induced
mortality at a rate 1 and natural mortality at the rate h .. Hence, we have the following equation describing the
dynamics of undiagnosed SBE victims:
dI
= S − (1 + 2 + 3 + 1 + h ) I . (3)
dt
The population of SBE victims diagnosed with mild conditions is generated by those SBE victims diagnosed
with mild conditions at the rate 1 and diminishes by those receiving treatment at the rate 1 and natural mortality at
the rate h .. Thus, we obtain the following equation for SBE victims diagnosed with mild conditions:
dI ml
= 1I − (1 + h ) I ml . (4)
dt
The population of SBE victims diagnosed with moderate conditions is generated by those SBE victims
diagnosed with mild conditions at the rate 2 and the population diminishes by those receiving treatment at a rate 2 ,
and natural mortality at the rate h . Thus, we obtain the following equation:
dI mo
= 2 I − ( 2 + h ) I mo . (5)
dt
The population of SBE victims diagnosed with severe conditions is generated by those SBE victims diagnosed
with severe conditions at the rate 3 , it diminishes by those receiving treatment at a rate 3 , SBE-induced mortality
at the rate 2 , and natural mortality at the rate h . Hence, we have the following equation:
dI s
= 3 I − ( 3 + 2 + h ) I s . (6)
dt
The population of SBE victims receiving treatment with ASV is generated by SBE victims diagnosed with
mild, moderate, and severe conditions at the rates 1 , 2 and 3 , respectively. This population is reduced by
proportions of persons who recovered with or without disability at a rate , those who suffer from early adverse
reactions at a rate and natural mortality at a rate h . Hence, we have the following equation:
dT
= 1I mi + 2 I mo + 3 I s − ( + + h ) T . (7)
dt
The population of persons suffering from early adverse reactions due to ASV treatment is generated by SBE
victims on treatment who suffer from early adverse reactions due to ASV at the rate . This population diminishes
due to those persons who recovered with or without disability at a rate and natural mortality at a rate h . Thus, we
have the following equation:
dEar
= T − ( + h ) Ear . (8)
dt
The population of persons recovered with disability is generated by the proportions of persons who recovered
with disabilities in the treatment class at the rate and in the early adverse reaction class at the rate . It
diminishes because of movement to a susceptible class at the rate 1 and natural mortality at the rate h . Hence, we
have the following equation:
dRd
= T + Ear − (1 + h ) Rd . (9)
dt
The population of persons who recovered without disabilities is generated by the proportions of persons in the
treatment class who recovered without disabilities at the rate (1 − ) and in the early adverse reaction classat the
rate (1 − ) . It diminishes because of transition to susceptible class at the rate 2 and natural mortality at the rate
h . Thus, we have the following equation:
dRw
= (1 − ) T + (1 − ) Ear − ( 2 + h ) Rw . (10)
dt
The venomous snake population increases at a rate s ,which is reduced by natural mortality rate s and human
activities induce mortality at a rate . Thus, we obtain the equation governing the dynamics of the venomous snakes
as
dVs
= s − ( + s )Vs . (11)
dt
2.1.3 The model equation
Therefore, the model describing the dynamics of SBE is given by the following system of first-order nonlinear
ordinary differential equations (the model schematic diagram is depicted in Fig. 1, and the associated state variables
and parameters are presented in Tables 1 and 2, respectively).
dS
= h + 1 Rd + 2 Rw − ( + P1 ) S ,
dt
dI
= S − P2 I ,
dt
dI ml
= 1 I − P3 I ml ,
dt
dI mo
= 2 I − P4 I mo ,
dt
dI s
= 3 I − P5 I s ,
dt
dT
= 1 I ml + 2 I mo + 3 I s − P6T ,
dt
dEar
= T − P7 Ear ,
dt
dRd
= T + Ear − P8 Rd ,
dt
dRw
= 1T + 2 Ear − P9 Rw , (12)
dt
dVs
= s − P10Vs ,
dt
Variable(s) Description
Parameter(s) Description
3. Results
1 1 0
Table 3: Reported data and the estimated values of the state variables
Variable(s) Value(s) Reference
Figure 2: Graph showing the results of the model fitting with the cumulative number of reported data on
undiagnosed SBE victims.
Figure 3: Graph showing the model results fitting with the cumulative number of reported data on SBE
victims diagnosed with mild conditions.
Figure 4: Graph showing the results of the model fitting with the cumulative number of reported data on SBE
victims diagnosed with moderate conditions.
Figure 5: Graph showing the results of the model fitting with the cumulative number of reported data on SBE
victims diagnosed with severe conditions.
Figure 6: Graph showing the results of the model fitting with the cumulative number of reported data on SBE
victims receiving treatment.
Figure 7: Graph showing the results of the model fitting with the cumulative number of reported data on
individuals suffering from early adverse reactions uring treatment.
Figure 8: Graph showing the results of the model fitting with the cumulative number of reported data on
persons who recovered with disabilities.
Figure 9: Graph showing the results of the model fitting with the cumulative number of reported data on
persons who recovered without disabilities.
Figure 10: Graph showing the results of the model fitting with the cumulative number of reported data on
SBE-induced deaths.
and humans, i.e., = 0 which also implies that the force of envenoming, = 0 . Therefore, the existence of snakebite-
*
envenoming free equilibrium point denoted by E is established and is presented as follows:
E * = ( S * , I * , I ml
* *
, I mo , I s* , T * , Ear* , Rd* , Rw* ,Vs* ) = h , 0, 0, 0, 0, 0, 0, 0, 0, s .
P1 P10
3.3.2 Existence of snakebite envenoming endemic equilibrium point
The Snakebite-envenoming endemic equilibrium point demonstrates a situation where SBE will persist in a
given community. Biologically, this can due to interaction between venomous snakes and humans, i.e., 0 , which
also implies the force of envenoming, 0 . Now, to obtain the conditions for the existence of the snakebite-
envenoming endemic equilibrium point,
Let E
**
= ( S ** , I ** , I ml
** **
, I mo , I s** , T ** , Ear** , Rd** , Rw** ,Vs** ) be an arbitrary endemic equilibrium point of the
model equation given by system (12). In addition, let
V **
= ** s
, (15)
N h**
be the associated force of envenoming of the model equation at steady state. Now, the equations of the model given by
system (12) are solved in terms of the force of envenoming at a steady state given by equation (15). Solving for the
state variables in the model equation given by system (12) at steady-state gives
h ** h 1 h ** 2 h ** 3 h **
S ** = , I ** = **
, I ml = *
, I mo = , I s** = ,
+ P1 P2 ( + P1 ) P2 P3 ( + P1 ) P2 P4 ( + P1 ) P2 P5 ( ** + P1 )
** ** ** **
Applying the Descartes Rule of Signs in each case showsthat only one sign changes, establishing the existence of one
**
positive real root, i.e., a unique snakebite-envenoming endemic equilibrium point of the model denoted by E is
established. Thus, the following proposition is presented:
Proposition [Link] 0 with either s P1 + h P10 s or s P1 + h P10 s , then the model equation
given by system (12) has a unique snakebite-envenoming endemic equilibrium point denoted by E ( ).
**
equilibrium point, E ( ) of the model equation given by system (12) are locally asymptotically stable (LAS) in the
**
region .
Proof. The Jacobian corresponding to the model equation given by system (12) is given as
Vs S
− N * − P1 0 0 0 0 0 0 0 0 −
N h*
h
Vs S
−P2 0 0 0 0 0 0 0
N h* N h*
0 1 −P3 0 0 0 0 0 0 0
,
0 2 0 −P4 0 0 0 0 0 0
J (X ) =
0 3 0 0 −P5 0 0 0 0 0
0 0 1 2 3 −P6 0 0 0 0
(17)
0 0 0 0 0 −P7 0 0 0
0 0 0 0 0 −P8 0 0
0 0 0 0 0 1 2 0 −P9 0
−P10
0 0 0 0 0 0 0 0 0
(
where X = S , I , I ml , I mo , I s , T , Ear , Rd , Rw , Vs ) and Nh = Nh* are taken as a constant for simplicity. Let
= 0 , so that the snakebite-envenoming free equilibrium, E * exists. Now, the Jacobian of the system (12)
*
evaluated at E is given by
− P1 0 0 0 0 0 0 0 0 0
0 −P 0 0 0 0 0 0 0 0
2
0 1 −P3 0 0 0 0 0 0 0
0 2 0 −P4 0 0 0 0 0 0
. (18)
3 −P5 0
J ( E* ) =
0 0 0 0 0 0 0
0 0 1 2 3 −P6 0 0 0 0
0 0 0 0 0 −P7 0 0 0
0 0 0 0 0 −P8 0 0
0 0 0 0 0 1 2 0 −P9 0
0 0 0 0 0 0 0 0 0 −P10
The characteristic equation of the Jacobian matrix evaluated at the snakebite-envenoming free equilibrium point given
by equation(18)is presented as
V*
(t ) = f1 I + f 2 I ml + f 3 I mo + f 4 I s + f 5T + f 6 Ear + f 7 1 − s Vs . (25)
Vs
Using the right-hand sides of system (12) in equation (24) we have
( t ) = f1 ( S − P2 I ) + f 2 (1I − P3 I ml ) + f3 (2 I − P4 I mo ) + f 4 (3 I − P5 I s )
V*
+ f5 ( 1 I ml + 2 I mo + 3 I s − P6T ) + f 6 ( T − P7 Ear ) + f 7 1 − s ( s − P10Vs ) . (26)
Vs
Expanding and collecting like terms in equation (26) and keeping into consideration that S N h the following
equation is obtained:
( t ) ( f 21 + f32 + f 43 − f1 (1 + 2 + 3 ) ) I − f1 (1 + h ) I + ( f51 − f 21 ) I ml − f 2 h I ml
+ ( f5 2 − f3 2 ) I mo − f3 h I mo + ( f5 3 − f 4 3 ) I s − f 4 ( 2 + h ) I s + ( f 6 − f5 P6 ) T − f 6 P7 Ear
sVs*
+ ( f1 − f 7 P10 )Vs − f 7 + f 7 s + f 7Vs* P10 . (27)
Vs
From equation (27) the following Lyaponuv coefficients were derived
P6
f1 = f 2 = f3 = f 4 = f5 = 1, f 6 = and f 7 = .
P10
(28)
Thus, equation (27) becomes
P6 P7 sVs*
( t ) − (1 + h ) I − h ( I ml + I mo ) − ( 2 + h ) I s − Ear − − s − Vs* P10 (29)
P10 Vs
Since = 0 , it follows that ( t ) 0, with ( t ) = 0, if I = I ml = I mo = I s = T = Ear = 0 . Since, is
positively invariant and attracting, The largest positive invariant set in is the singleton E .Thus, according to
*
*
LaSalle’s invariance principle [38],the snakebite-envenoming free equilibrium point E is globally attractive.
Therefore, the snakebite-envenoming free equilibrium point is globally asymptotically stable.
Theorem 4. The snakebite-envenoming endemic equilibrium point of the model is globally asymptotically stable in
the region Ω.
Proof. Suppose the result in Proposition 1 holds so that the existence of unique snakebite-envenoming endemic
equilibrium point is assured. Consider the following quadratic Lyapunov function with the following candidate:
G( X ) = 1 ( S − S ** ) + 2 ( I − I ** ) + 3 ( I ml − I ml ) + g24 ( I mo − I mo** ) + g25 ( I s − I s** ) + g26 (T − T ** )
g 2 g 2 g ** 2 2
2 2 2
+ 7 ( Ear − Ear** ) + 8 ( Rd − Rd** ) + 9 ( Rw − Rw** ) + 10 (Vs − Vs** ) ,
g 2 g 2 g 2 g 2
(30)
2 2 2 2
where X = S , I , I ml , I mo , I s , T , Ear , Rd , Rw ,Vs .
Now, differentiating equation (30) along the solution of the model equation given by system (12) and choosing
gi = 1, ( i = 1, 2,3,...10 ) gives
= ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo ) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** )
dG **
dt
d dV
S + I + I ml + I mo + I s + T + Ear + Rd + Rw + Vs − Vs** s . (31)
dt dt
From system (12), we have
d
S + I + Iml + Imo + I s + T + Ear + Rd + Rw = h − h S + I + Iml + Imo + I s + T + Ear + Rd + Rw − 1I − 2 I s (32)
dt
and
dVs
= s − P10Vs . (33)
dt
Using equations (32) and (33) in equation (31), we obtain
= ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo ) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** )
dG **
dt
h − h S + I + I ml + I mo + I s + T + Ear + Rd + Rw − 1I − 2 I s + Vs − Vs** s − P10Vs . (34)
At steady state, we have
+ I s** + T ** + Ear** + Rd** + Rw* + 1I ** + 2 I s** and s = P10Vs .
**
h = h S ** + I ** + I ml
**
+ I mo
**
(35)
Substituting equation (35) in equation (34) gives
= ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo ) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** )
dG **
dt
h S ** + I ** + I ml
**
+ I mo
**
+ I s** + T ** + Ear** + Rd** + Rw* + 1I ** + 2 I s** − h S + I + I ml + I mo + I s + T + Ear + Rd + Rw
dt
−h ( S − S ** ) − h ( I − I ** ) − h ( I ml − I ml** ) − h ( I mo − I mo
**
) − h ( Is − Is** ) − h (T − T ** ) − h ( Ear − Ear** ) − h ( Rd − Rd** ) − h ( Rw − Rw** )
−1 ( I − I ** ) − 2 ( I s − I s** ) − P10 (Vs − Vs** )(Vs − Vs** ) . (37)
After expansion and some series of simplifications, the following equation is obtained:
= − ( S − S ** ) h ( S − S ** ) + 1 + − ( I − I ** ) h ( I − I ** ) + 2 +
dG
dt
( ) (
) **
(
) ( **
)
− I ml − I ml h I ml − I ml + 3 + − I mo − I mo h I mo − I mo + 4 +
** **
− ( I − I ) ( I − I ) + + − (T − T ) (T − T ) + +
** ** ** **
s s h s s 5 h 6
− ( E − E ) ( E − E ) + + − ( R − R ) ( R − R ) + +
** ** ** **
ar ar h ar
ar 7 d d h d d 8
where
1 = ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
2 = ( S − S ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
3 = ( S − S ** ) + ( I − I ** ) + ( I mo − I mo
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
4 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
5 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
6 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + ( I s − I s** ) + ( Ear − Ear** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
7 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml
**
) + ( I mo − I mo** ) + ( I s − I s** ) + (T − T ** ) + ( Rd − Rd** ) + ( Rw − Rw** ) ,
8 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rw − Rw** ) ,
9 = ( S − S ** ) + ( I − I ** ) + ( I ml − I ml** ) + ( I mo − I mo
**
) + ( I s − I s** ) + (T − T ** ) + ( Ear − Ear** ) + ( Rd − Rd** ) ,
= 1 ( I − I ** ) + 2 ( I s − I s** ) .
dG dG
0 and = 0 if and only if S = S ** , I = I ** , I ml = I ml , I mo = I mo ,
** **
From equation (38) it is clear that
dt dt
I s = I s** , T = T ** , Ear = Ear** , Rd = Rd** , Rw = Rw** , Vs = Vs** . Furthermore, every solution of the model equation
given by system (12) approaches the snakebite-envenoming endemic equilibrium, E ( ) as t → . Hence, the
**
4. Numerical Simulations
The data in Tables 3 and 4 are used as baseline values for the state variable and the parameters of the model.
Numerical simulations to investigate the impacts of the diagnosis of SBE victims and the treatment with ASV on the
the burden of SBE were performed. The diagnosis- and treatment-related parameters were varied as low (25%),
moderate (50%), and high (75%). The results of the simulations of the model showing the impacts of the diagnosis of
SBE victims and the treatment with ASV on the burden of SBE in terms of SBE-induced deaths and disability are
presented in Figures. 11 and 12, respectively. The simulation result in Figure 11 clearly shows that an increase in the
rates of diagnosis of SBE victims combined with ASV treatment resulted in a reduction in the burden of SBE in terms
of SBE-induced deaths presented for one year. Similarly, the outcome of the simulation depicted in Figure 12 reveals
that when rates of diagnosis of SBE victims and treatment with ASV are increased, the number of SBE-induced
disabilities prevented increases. It is worth noting that when the rate of diagnosis of SBE victims and treatment with
ASV is set to zero, the number of SBE-induced deaths and disabilities increases. The results of these numerical
simulations indicate that the diagnosis of SBE victims for proper treatment with ASV will help in the struggle against
SBE in terms of reducing its burden. Thus, the affected community should be encouraged to always visit the hospital
for proper diagnosis of SBE victims and treatment with ASV.
Figure 11: Simulation showing the impact of diagnosis and treatment with ASV on SBE-induced deaths
Figure 12: Simulation showing the impact of diagnosis and treatment with ASV on SBE-induced disability
5. Conclusion
In this work, a population-based mathematical model was developed to investigate the impact of the
diagnosis of SBE victims and treatment with ASV. The basic properties of the model in terms of positivity and
boundedness of the model solution were explored. The model is fitted using real data on SBE collected from
snakebite treatment and research hospitals in Kaltungo, Gombe State, in northeast Nigeria. The dynamical
behavior of the model in terms of equilibrium points and their associated stability analyses were carried out.
Furthermore, numerical simulations of the model were performed. Thus, the main qualitative and
epidemiological findings of this study are summarized as follows:
i. the outcome of the model fitting has shown that the model fitted well with the real data, suggesting that
the model can be used to study the dynamics of SBE in a given community;
ii. the qualitative study of the model has established that the model has two equilibrium points, namely,
snakebite-envenoming free and snakebite-envenoming endemic;
iii. the results of the stability analyses revealed that both the two equilibrium points, i.e., snakebite-
envenoming free and snakebite-envenoming endemic, are locally and globally asymptotically stable;
iv. numerical simulations of the model have shown that diagnosis of SBE victims and treatment with ASV
could reduce the burden of SBE in terms of preventing the number of SBE-induced deaths and
disabilities.
Therefore, based on the epidemiological findings in this work, we recommend that people living in a
high-risk community be encouraged to attend health facilities for appropriate diagnosis of snakebite victims
and treatment.
Acknowledgments
The authors appreciate the comments of reviewers and the editor, which were constructive to improve the
clarity of the manuscript. I sincerely express my gratitude to Prof. I. I. Adamu of the Department of Mathematics,
Modibbo Adama University Yola for thorough supervision of this work. A Special thanks to Abdullahi, S. A
(Ph.D) for assisting with the coding and general organization of this paper. We acknowledge Dr. Abubakar S.
Balla of Snakebite Treatment and Research Hospital Kaltungo, Gombe state for updating us (on consulting) with
relevant informations on management of snakebite envenoming patients. Also, we are thankful to the Snakebite
Control Network (S-CONET) for their professional inputs.
References
Warrell, D. A. (2010). Snake bite. Lancet, 375(9708), 77–88. [Link] S0140-6736(09)61754-2
Williams D.J., Faiz M.A., Abela-Ridder B., Ainsworth S., Bulfone T.C., Nickerson A.D., Habib A.G., Junghanss T.,
Fan H.W., & Turner M. (2019). Strategy for a Globally Coordinated Response to a Priority Neglected Tropical
Disease: Snakebite Envenoming. PLoS Neglected Tropical Disease, 13:e0007059.
WHO (2019). Snakebite Envenoming: a Strategy for Prevention and Control. World Health Organization.
[Link]
Longbottom J., Shearer F. M., Devine M., Alcoba G., Chappuis F., & Weiss D. J (2018). Vulnerability to Snakebite
Envenoming: a Global Mapping of Hotspots. The Lancet, 392(10148), 673–684. [Link]
6736(18)31224-8 PMID: 30017551
Gampini S., Nassouri S., Chippaux J. P., & Semde R. (2016). Retrospective Study on the Incidence of Envenomation
and Accessibility to Antivenom in Burkina Faso. Journal of Venomous Animals and Toxins Including Tropical
Diseases, 22(1), 1–5. [Link]
Harrison, R. A., & Williams, D. J. (2019). Outlining progress since the first International Snakebite Awareness Day
and some key challenges for next year .Transactions of The Royal Society of Tropical Medicine and Hygiene,
113(10), 577–578. [Link] org/10.1093/trstmh/trz096
Gutierrez, J. M., Bruno, L., Guillermo, L., Alexandra, R., Fernando, C., & Yamileth, A. (2007). Trends in Snakebite
Envenomation Therapy: Scientific, Technological and Public Health Considerations. Current Pharmaceutical
Design, 13 (28), 2935−2950. doi: 10.2174/138161207782023784
Gutierrez, J. M., Calvete, J.J., Habib, A.G., Harrison, R.A., Williams, D.J., & Warrell, D.A. (2017). Snakebite
Envenoming. Nature Review Disease Primers, 3. e17063.
Habib, A. G & Brown, N. I. (2018). The Snakebite Problem and Antivenom Crisis from a Health-Economic
Perspective. Toxicon, 150, 115–123. [Link]/10.1016/[Link].2018.05.009
Gold, B. S., Dart, R. C., Barish, & R. A. (2002). Bites of Venomous Snakes. New England Journal of Medicine, 347,
347–356. DOI: 10.1056/NEJMra013477
Beri, D. Bhaumik, S. - Snakes, the Ecosystem, and Us: It’s Time we Change. The George Institute of Global Health.
July 2023. Available online at [Link]. The article is licensed under CC BY-NC 2.0.
Katie, V. and Kennymac (2013) Wildlife Epidemiology Laboratory. Why You Should Care about Snakes.
[Link] .Accessed September, 2023.
Abdullahi, Z. U., Musa, S. S., He, D. & Bello, U. M. (2021). Antiprotozoal Effect of Snake Venoms and their
Fractions. Pathogens, 10, 1632. [Link]/10.3390/pathogens10121632.
Abubakar, S. B., Abubakar, I. S., Habib, A. G., Nasidi, A., Durfa, N., Yusuf, P. O., Larnyang, S., Garnvwa, J.,
Sokomba, E., Salako, L., Theakston, R. D., Juszczak, E., Alder, N., & Warrell, D. A. (2010). Randomized
Double Blind Comparative Trial of Two Antivenoms for the Treatment of Patients Envenomed by the Saw-Scaled
or Carpet Viper (Echisocellatus) in Northern Nigeria. PLoS Neglected Tropical Disease, 4, e767.
[Link]
Agom, D. I., Moses, B. A., & Priti, M. (2022, December, 3). Tackling Snakebite at the Community Level to
Mitigate Disability Worldwide. International Day of People with disability presented at the annual conference of
the Int’l Society for Neglected Tropical Disease. International Society for Neglected Tropical Diseases.
[Link]/isntd-connect. Availble on [Link]
Alams, M. I., & Gomes, A. (2003) Snake venom Neutralization by Indian Medicinal Plant (Vitexnegundo and
Emblicaofficinalis) Root Extracts. Journal of Ethnopharmcology, 86, 75-80.
[Link]
Zainal Abidin, S. A., Lee, Y. Q., Lekhsan, Y. O. & Rakesh, N. (2019). Malaysian Cobra Venom: a Potential
Source of Anti-Cancer. Toxins, 11.
Hussaini, N., Okuneye, K. & Gumel, A. B. (2017). Mathematical Analysis of a Model for Zoonotic Visceral
Leishmaniasis. Infectious Disease Modelling, 2, 455-474
Adamu, L. & Hussaini, N. (2019). An Epidemic Model of Zoonotic Visceral Leishmaniasis with Time Delay.
Journal for Nigeria Society of Physical Science, 1, 20−29.
Shigui, R. (2017). Modeling the Transmission Dynamics and Control of Rabies in China. Mathematical Biosciences,
286, 65 - 93.
Zhang, J., Jin, Z., Sun, G-Q., Zhou, T., Ruan, S. (2011). Analysis of Rabies in China: Transmission Dynamics and
Control. PLoS ONE, 6(7): e20891.
Yakob, L., Clements, A. C. A. (2013). A Mathematical Model of Chikungunya Dynamics and Control: The Major
Epidemic on Reunion Island. PLoS ONE, 8(3):e57448.
Sabiu, S.M. & Hussaini, N. (2017). Modeling the Dynamics of Dengue Virus in Human and Mosquito Populations.
Journal of Nigerian Association of Mathematical Physics, 43.
Bhunu, C. P & Mushayabasa, S. (2012). Transmission Dynamics of Lymphatic Filariasis:a Mathematical Approach.
ISRN Biomathematics, [Link]
Dumont, Y. & Chiroleu, F. (2010). Vector Control for the Chikungunya disease. Mathematical Biosciences and
Engineering, 7.
Omondi, E.O., Nyabadza, F., Bonyah, E. & Badu, K. (2017). Modeling the Infection Dynamics of Onchocerciasis
and its Treatment. Journal of Biological Systems, 25(2), 1−31. doi:10.1142/S0218339017500139.
Sabiu, S.M., Hussaini, N., Zhao, S. & Daihai H. (2020). Dynamical Analysis of Chikungunya and Dengue
Coinfection Model. Discrete and Continuous Dynamical System Series B, 25(5), 1907-1933.
Woolhouse, M.E.J. (1992). On the Application of Mathematical Models of Schistosome Transmission Dynamics. II
Control. Acta Trop. 50, 189-204.
Bravo-Vega, C.A., Cordovez, J.M., Renjifo-Ibanez, C., Santos-Vega, M., & Sasa, M. (2019). Estimating Snakebite
Incidence from Mathematical Models: A Test in Costa Rica. PLoS Neglected Tropical Disease, 13(12):
e0007914.
Kim S. (2020). Introduction of a Mathematical Model to Characterize Relative Risk of Snakebite Envenoming, a
Neglected Tropical Disease. [Thesis]: the degree of Honors Baccalaureate of Science in Kinesiology: Oregon
State University, University Honors College.
Goldstein, E., Erinjery, J.J., Martin, G., Kasturiratne, A., Ediriweera, D.S. & de Silva, H.J. (2021).Integrating Human
Behavior and Snake Ecology with Agent-Based Models to Predict Snakebite in High Risk Landscapes. PLoS
Neglected Tropical Disease, 15(1): [Link]
Abdullahi, S.A., Habib, A.G. and Hussaini, N.: (2021). Control of Snakebite Envenoming: A Mathematical
Modeling Study. PLOS Neglected Tropical Diseases 15(8): e0009711.
[Link] (2021).
Bravo-Vega, C., Santos-Vega, M & Juan, Cordovez, J. M. (2021). Entangling Snakebite Dynamics: the
Spatiotemporal Role of Rainfall on Snake Envenoming in Colombia, 2021,Cold Spring Harbor Laboratory,
doi: 10.1101/2021.07.13.452215
Martin, G., Erinjery, J.J., Ediriweera, D., de Silva, H.J., Lalloo, D.G., Iwamura, T. & Murray, K.A. (2022). A
Mechanistic Model of Snakebite as a Zoonosis Envenoming Incidence is Driven by Snake Ecology,
Socioeconomics and its Impacts on Snakes. PLoS Neglected Tropical Disease 2022 May 12 (5) 16:e0009867.
doi: 10.1371/[Link].0009867.
Kumar,P. Vedat Suat Erturk, V. Govindaraj, & Baleanu, D. (2023). A Study on the Nonlinear Caputo-Type
Snakebite Envenoming Model with Memory. Computer Modeling in Engineering & Sciences, 136(3), 2487–2506.
[Link]
Abdullahi, S.A., Habib, A.G. & Hussaini, N. (2024). Mathematical Analysis for the Dynamics of Snakebite
Envenoming. Afrika Matematika, 35, 16 (2024). [Link]
Yañez-Arenas, C., Peterson, A. T., Mokondoko, P., Rojas-Soto, O. & Martínez-Meyer, E. (2014). The Use of
Ecological Niche Modeling to Infer Potential Risk Areas of Snakebite in the Mexican State of Veracruz. PLoS
ONE, 9(6). [Link]
Masoud, Y., Anooshe, K., and Ali, K., & Nima. N. (2020). Applying Species Distribution Models in Public Health
Research by Predicting Snakebite Risk Using Venomous Snakes’ Habitat Suitability as an Indicating Factor.
Nature Search, 10(1). [Link]
Casewell, N. R., Clevers, H. (2020). Snake Venom Gland Organoids. Cell, 80(2), 233-247.
doi: 10.1016/[Link].2019.11.038.
Menez, A (2003) The Subtle Beast. Snake, from Myth to Medicine, 1st ed, CRC Press.
[Link]
Warrel, D. A. (1996). Animal Toxins. In Gordon Cook. Manson's Tropical Diseases, 20th Ed. London: WB Saunders.